1,2 At baseline, 95% of patients were treated with an ACE inhibitor or ARB, 16% were on an SGLT-2i, 76% were on a statin, and 50% were on an antiplatelet agent
The good news: nausea is usually temporary
You still get substantial GLP-1 and GIP receptor activation with meaningful glucagon engagement
As Long COVID is a continuation of pathologies found in the acute phase of the disease, it can be suggested that erythrocyte pathologies noted in acute COVID-19 may continue or even be exacerbated in Long COVID
In addition to weight management, the drug is also approved to treat obstructive sleep apnea in people with obesity
At our pracrice, we understand the importance of personalized care, and our team will work with you to tailor a semaglutide GLP-1 treatment plan that aligns with your specific needs and lifestyle